Proteinuria
Clinical trials for Proteinuria explained in plain language.
Never miss a new study
Get alerted when new Proteinuria trials appear
Sign up with your email to follow new studies for Proteinuria, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New kidney drug could help kids with protein leak
Disease control OngoingThis study tests whether adding finerenone to standard blood pressure medicines can reduce protein in the urine of children with chronic kidney disease. About 219 children aged 6 months to under 18 years will take either finerenone or a placebo for 6 months. The main goal is to s…
Matched conditions: PROTEINURIA
Phase 3 • Sponsor: Bayer • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New hope for transplant patients: drug targets kidney protein leak
Disease control OngoingThis study tests a drug called sparsentan for people who have protein in their urine after a kidney transplant due to IgA nephropathy or FSGS. About 20 adults will take the drug once daily for 36 weeks to see if it safely reduces protein levels and protects kidney function. The g…
Matched conditions: PROTEINURIA
Phase 4 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New combo therapy may shield diabetic kidneys from damage
Disease control OngoingThis study tests whether adding an SGLT2 inhibitor to standard ARB therapy better reduces protein in the urine (a sign of kidney damage) in diabetic patients without high blood pressure. Sixty adults aged 30-60 with diabetes and microalbuminuria will receive either ARBs alone or …
Matched conditions: PROTEINURIA
Phase 2/3 • Sponsor: Dr Mudassar Saeed Pansota • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC